Literature DB >> 11233912

Donor cytokine genotype influences the development of acute rejection after renal transplantation.

S E Marshall1, A J McLaren, E F McKinney, T G Bird, N A Haldar, M Bunce, P J Morris, K I Welsh.   

Abstract

BACKGROUND: Acute allograft rejection remains an important cause of morbidity after kidney transplantation, and has been shown to be a crucial determinant of long-term graft function. Although rejection is mediated by recipient lymphocytes, both donor and recipient factors contribute to the local environment that influences the nature, severity, and duration of the rejection response. Cytokines are a major determinant of this milieu, and this study sought to explore the impact of donor cytokine and cytokine receptor gene polymorphisms on acute rejection after renal transplantation.
METHODS: A total of 145 cadaveric renal allograft donors were selected for analysis according to the presence or absence of graft rejection in the first 30 days after transplantation. DNA was genotyped for 20 polymorphisms in 11 cytokine and cytokine receptor genes using the polymerase chain reaction with sequence specific primers. Associations were assessed using contingency table analysis and the chi2 test, using a two-set design.
RESULTS: A polymorphism at position -174 of the donor IL-6 gene was associated with the incidence (P=0.0002) and severity (P=0.000007) of recipient acute rejection. This finding was independent of HLA-DR matching. Acute rejection was not influenced by recipient IL-6 genotype, or by donor-recipient matching of IL-6 genotype.
CONCLUSION: This study identifies donor IL-6 genotype as a major genetic risk factor for the development of acute rejection after renal transplantation. This provides evidence that donor-derived cytokines play a major role in determining outcome after transplantation, and will contribute to the development of therapeutic algorithms to predict individuals at particularly high risk of acute rejection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11233912     DOI: 10.1097/00007890-200102150-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

Review 1.  Genetic predisposition and renal allograft failure: implication of non-HLA genetic variants.

Authors:  Faisal Khan; Swati Agrawal; Suraksha Agrawal
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

2.  The impact of interleukin-6 promoter -597/-572/-174genotype on interleukin-6 production after lipopolysaccharide stimulation.

Authors:  M Müller-Steinhardt; B Ebel; C Härtel
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

3.  Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A.

Authors:  William S Oetting; David P Schladt; Casey R Dorr; Baolin Wu; Weihua Guan; Rory P Remmel; David Iklé; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; Pamala A Jacobson
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

Review 4.  Genetics of acute rejection after kidney transplantation.

Authors:  Casey R Dorr; William S Oetting; Pamala A Jacobson; Ajay K Israni
Journal:  Transpl Int       Date:  2017-11-08       Impact factor: 3.782

5.  Influence of recipient and donor IL-10, TNFA and INFG genotypes on the incidence of acute renal allograft rejection.

Authors:  Negar Azarpira; Mahdokht H Aghdai; Ghanbar A Raisjalali; Masumeh Darai; Moham J Tarahi
Journal:  Mol Biol Rep       Date:  2008-09-16       Impact factor: 2.316

6.  Influence of recipient and donor IL-1alpha, IL-4, and TNFalpha genotypes on the incidence of acute renal allograft rejection.

Authors:  H Lee; B Clark; H C Gooi; J Stoves; C G Newstead
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

7.  Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature.

Authors:  Catharina M Mulders-Manders; Marije C Baas; Femke M Molenaar; Anna Simon
Journal:  Front Pharmacol       Date:  2017-05-31       Impact factor: 5.810

8.  Precision Medicine in Kidney Transplantation: Just Hype or a Realistic Hope?

Authors:  Ehsan Nobakht; Muralidharan Jagadeesan; Rohan Paul; Jonathan Bromberg; Sherry Dadgar
Journal:  Transplant Direct       Date:  2021-01-07

9.  HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.

Authors:  Bjarte Fosby; Sigrid Næss; Johannes R Hov; James Traherne; Kirsten M Boberg; John Trowsdale; Aksel Foss; Pål-Dag Line; Andre Franke; Espen Melum; Helge Scott; Tom H Karlsen
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

10.  No Major Effect of Innate Immune Genetics on Acute Kidney Rejection in the First 2 Weeks Post-Transplantation.

Authors:  Rong Hu; Daniel T Barratt; Janet K Coller; Benedetta C Sallustio; Andrew A Somogyi
Journal:  Front Pharmacol       Date:  2020-02-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.